Anti-BCMA CAR-T therapy

BCMA-targeted chimeric antigen receptor T-cell therapy

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Anti-BCMA CAR-T therapy, covering 2025-05-09 to 2025-07-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Anti-BCMA CAR-T Therapy in Newly Diagnosed Myeloma Patients Who Are Transplant-ineligible [NA]